Hormone naïve
Showing 26 - 50 of 6,908
Cognitive Functioning and Functional Status in Prostate Cancer
Active, not recruiting
- Prostate Cancer
- Questionaires
- fMRI scan (optional)
-
Duarte, California
- +1 more
Mar 18, 2022
Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))
Active, not recruiting
- Prostatic Neoplasm
- Docetaxel
- Androgen-Deprivation Therapy (ADT)
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 6, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)
Recruiting
- Prostate Cancer
- Hypoxia
- Optional non-IMP pimonidazole
- +8 more
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Jan 26, 2023
Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)
Withdrawn
- Solid Tumor
- Advanced Breast Cancer
- Abemaciclib
- +6 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022
Breast Cancer Trial in Shanghai (HS-10352 combined with fulvestrant (Stage 1), HS-10352 combined with fulvestrant (Stage 2))
Recruiting
- Breast Cancer
- HS-10352 combined with fulvestrant (Stage 1)
- HS-10352 combined with fulvestrant (Stage 2)
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 15, 2022
Thyroid Cancer Trial (device, dietary supplement, drug)
Not yet recruiting
- Thyroid Cancer
- X-BOX kinetic360
- +2 more
- (no location specified)
Feb 23, 2022
Sensitivity of 'Questionnaire to Screen for HYpothyroidism'
Recruiting
- Hypothyroidism
- Healthy
- Blood test for Thyroid stimulating hormone (TSH)
-
Mumbai, Maharashtra, India
- +10 more
Jul 12, 2022
Rectal Mucosa Immune Environment in Transgender Women
Recruiting
- HIV Prevention
- Estrogen
- Estrogen plus Progesterone
-
Atlanta, GeorgiaHope Clinic
Mar 15, 2022
Hypoparathyroidism Trial in Birmingham (Parathyroid Allotransplant)
Recruiting
- Hypoparathyroidism
- Parathyroid Allotransplant
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Mar 8, 2022
Prostate Cancer Patients Treated With 6-month Triptorelin
Not yet recruiting
- Prostate Cancer
- (no location specified)
Mar 6, 2023
Breast Cancer Stage IV, Radiotherapy, Surgery Trial in France (Palbociclib, locoregional treatment)
Recruiting
- Breast Cancer Stage IV
- +2 more
- Palbociclib
- locoregional treatment
-
Angers, France
- +25 more
Sep 1, 2022
Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)
Recruiting
- Prostate Cancer
- Prostate Cancer Metastatic
-
La Jolla, California
- +1 more
Feb 2, 2023
Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- 225^Ac-PSMA-617
- 68^Ga-PSMA-11
-
Darlinghurst, Australia
- +1 more
Nov 23, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Binimetinib
- +5 more
- (no location specified)
Nov 8, 2022
Prostate Cancer Trial in France (antiandrogen therapy, docetaxel, goserelin acetate)
Completed
- Prostate Cancer
- antiandrogen therapy
- +3 more
-
Angers, France
- +40 more
Feb 19, 2021
Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)
Recruiting
- Prostate Cancer Patients
- Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
-
Qingdao, Shandong, China
- +1 more
May 3, 2022
Prostate Cancer Trial (Darolutamide 300 mg, Placebo of Darolutamide)
Not yet recruiting
- Prostate Cancer
- Darolutamide 300 mg
- Placebo of Darolutamide
- (no location specified)
Feb 10, 2022
Central Precocious Puberty (CPP) Trial in Puerto Rico, United States (Leuprolide Acetate (LA))
Active, not recruiting
- Central Precocious Puberty (CPP)
- Leuprolide Acetate (LA)
-
Long Beach, California
- +20 more
Sep 9, 2022